Marco A Calzado
banner
marcoacalzado.bsky.social
Marco A Calzado
@marcoacalzado.bsky.social
Professor @uco.es, Scientist @IMIBIC, Immunologist, Molecular Biologist, Father, and Technology Enthusiast.
📉 Se me han bajado los niveles de dopamina, y la única cura es: vacaciones.😎 La ciencia puede seguir sin mí… al menos unos días (o eso quiero creer). 😂😂 👋 Nos vemos cuando recupere mi homeostasis.
the sun shines through the trees in the foreground
ALT: the sun shines through the trees in the foreground
media.tenor.com
July 30, 2025 at 5:36 AM
Paper accepted! We’re thrilled and ready to celebrate a job well done.
More details coming soon… but today, we raise a glass. 🥂 Stay tuned!
#Science #Research
July 10, 2025 at 11:30 AM
Salir a correr en Córdoba después de las 9:00 a.m. no es deporte, es una prueba de supervivencia. Se llama: 100 metros deshidratado estilo lagarto en asfalto. 🦎🔥💀🏃🏻🏃🏻‍♂️
a man wearing headphones is sweating while sitting in an airplane .
ALT: a man wearing headphones is sweating while sitting in an airplane .
media.tenor.com
June 21, 2025 at 11:16 AM
Excited to share that I’m now part of the Editorial Board of Oncogene. I’ve long been a fan of the journal and look forward to contributing to its continued excellence #Oncogene #NaturePublishingGroup

www.nature.com/onc/
Oncogene
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. Oncogene propagates ...
www.nature.com
June 16, 2025 at 2:32 PM
Reposted by Marco A Calzado
Springer-Nature launched a series of "Discover" journals that closely mimic MDPI titles -- sharing *identical* journal names, and likely similar business model.

What is going on, and why researcher will - as always - fall for it?

A 🧵

the-strain-on-scientific-publishing.github.io/website/post...
Springer Nature Discovers MDPI – The Strain on Scientific Publishing
Home page for the paper ‘The Strain on Scientific Publishing’ by Mark A Hanson, Dan Brockington, Paolo Crosetto and Pablo Gomez Barreiro
the-strain-on-scientific-publishing.github.io
June 15, 2025 at 2:21 PM
Reposted by Marco A Calzado
To accelerate #mRNA vaccine and therapy research, we're excited to share our end-to-end protocol for mRNA design, synthesis and encapsulation in @natprot.nature.com.

Protocol development led by @laura-leighton.bsky.social, Natasha Chaudhary and Tim Mercer.@basemrna.bsky.social

rdcu.be/eqiF1
The design, manufacture and LNP formulation of mRNA for research use
Nature Protocols - This protocol describes simple, small-scale laboratory production of mRNA for research and preclinical use. This includes sequence design, DNA template production, mRNA synthesis...
rdcu.be
June 10, 2025 at 11:39 PM
Off goes the revised manuscript, fatter and wiser after surviving another round of experiments. May the reviewers be kind, merciful… and slightly distracted. 🤞📤 #Resubmitted #ReviewerBeNice
a woman in a black jacket is giving the middle finger while standing in the water .
ALT: a woman in a black jacket is giving the middle finger while standing in the water .
media.tenor.com
June 11, 2025 at 3:16 PM
Reposted by Marco A Calzado
Researchers in Science have developed a tool to silence specific mitochondria-encoded mRNAs in living cells, which could help scientists understand the origins of certain mitochondria-related diseases. scim.ag/3F6Wm5d
Silencing mitochondrial gene expression in living cells
Mitochondria fulfill central functions in metabolism and energy supply. They express their own genome, which encodes key subunits of the oxidative phosphorylation system. However, central mechanisms u...
scim.ag
May 23, 2025 at 7:23 PM
Reposted by Marco A Calzado
The papers all follow a similar template and make misleading claims

https://go.nature.com/4kucwEH
AI linked to explosion of low-quality biomedical research papers
Analysis flags hundreds of studies that seem to follow a template, reporting correlations between complex health conditions and single variables based on publicly available data sets.
go.nature.com
May 21, 2025 at 12:46 PM
Reposted by Marco A Calzado
Reposted by Marco A Calzado
Researchers report that their new #AI has, in a matter of months, conjured up dozens of GPCR-targeting antibody candidates, which promise to work as well as drugs that have spent years in the traditional pipeline. scim.ag/3S4gjwb
AI conjures up potential new antibody drugs in a matter of months
Company finds candidates that bind to tricky proteins that deliver chemical messages in and out of cells
scim.ag
May 14, 2025 at 4:06 PM
Reposted by Marco A Calzado
A new #ScienceAdvances study identifies a neuroimmune pathway for treating sepsis, finding that dopamine inhibits expression of a critical regulator of immunometabolism.

This suggests that pramipexole, a dopamine agonist, could effectively treat lethal infections. scim.ag/4kfAfrZ
A neuroimmune pathway drives bacterial infection
Dysregulation of the dopamine-ACOD1 axis correlates with sepsis severity.
scim.ag
May 13, 2025 at 6:55 PM
Reposted by Marco A Calzado
Reposted by Marco A Calzado
The @ukdri.ac.uk is recruiting a Research Associate to investigate how E3 ubiquitin ligases drive degradation of protein aggregates in neurodegenerative disease. Closing date: 25th May

www.dementiaresearcher.nihr.ac.uk/job/research...
Research Associate: Neurodegeneration and Protein Degradation
The UK DRI at Cambridge is recruiting a Research Associate to investigate how E3 ubiquitin ligases drive degradation of protein aggregates in neurodegeneration
www.dementiaresearcher.nihr.ac.uk
May 11, 2025 at 8:11 PM
Reposted by Marco A Calzado
Targeting an overlooked protein complex could offer a fresh avenue to cancer therapy

https://go.nature.com/3Z8R7IJ
Blocking a key node in cancer signalling unlocks therapeutic potential
Mutations in RAS enzymes commonly drive cancer. Targeting an overlooked protein complex that works with RAS offers a fresh avenue to cancer therapy.
go.nature.com
May 8, 2025 at 12:17 PM
Reposted by Marco A Calzado
Nature research paper: Cell cycle duration determines oncogenic transformation capacity.

https://go.nature.com/3GBSklB
Cell cycle duration determines oncogenic transformation capacity - Nature
Total cell cycle duration is a key hallmark of cancer initiation, and determines whether defects in apoptosis, senescence, immune surveillance, angiogenesis, DNA repair, polarity and proliferation lead to cancer development.
go.nature.com
May 5, 2025 at 7:00 AM
Reposted by Marco A Calzado
Lepodisiran, an extended-duration, small interfering RNA, reduced lipoprotein(a) concentrations in participants with elevated levels. Full ALPACA trial results and Research Summary: nej.md/4kWjJyn

#MedSky #CardioSky
May 4, 2025 at 7:02 PM
Nos conocimos hace 16 años como Ramón y Cajal y hemos compartido mucho desde entonces. Hoy, Catedráticos de Química Analítica, Ing. Hidráulica e Inmunología. Excelentes profesionales y mejores personas. La #uco tiene suerte de tenerlos a ambos como Profesores e Investigadores.
April 4, 2025 at 5:33 PM
Article submitted!
han solo from star wars is pointing at the camera with his finger .
ALT: han solo from star wars is pointing at the camera with his finger .
media.tenor.com
March 20, 2025 at 4:09 PM
Why don’t you wear a suit? 🤮😔
March 1, 2025 at 7:29 PM
Hoy, #DíaMundialContraElCáncer, recordamos que la investigación es clave. Hemos avanzado mucho en terapias dirigidas e inmunoterapia, pero aún queda mucho por hacer. Seguimos trabajando para entender mejor el cáncer y desarrollar mejores tratamientos. @univcordoba.bsky.social @imibic.bsky.social
February 4, 2025 at 8:49 PM
Today, we had the privilege of having @prieto-garcia.bsky.social at @IMIBIC talking about splicing, USP38, and proteostasis. A magnificent talk and excellent work! 🧬🧪🧫
January 23, 2025 at 5:24 PM
Reposted by Marco A Calzado
It was great to share Science with people at the
IMIBIC! Great place 🙂. Really thanks to Manuel D. Gahete for the invitation and thanks to @marcoacalzado.bsky.social , Raul , @betsaidaop.bsky.social and others for nice time and plenty Scientific discussions.
Enjoying the Seminar by @prieto-garcia.bsky.social at the IMIBIC on Proteotoxic Cryptic Splicing in Diseases: the pathologically relevant interplay between #splicing, #proteostasis #ER-Phagy
January 23, 2025 at 5:09 PM